California says the sale of 23andMe to a nonprofit formed by the company's former CEO would skirt a state law specifically ...

Study shows >95% success rate, validating BE-Smart for use with esophageal brush cytology. UNIONDALE, NY, June 17, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the "Company” or ...

Market Growth Driven by Increasing Consumer Awareness About Personalized Medicine, Growing Interest in Ancestry Research, Rising Prevalence of Chronic Diseases, and Technological Advancements ...